Gregory B. Lesinski
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, CAR-T cell therapy research, Cytokine Signaling Pathways and Interactions, Immunotherapy and Immune Responses
Most-Cited Works
- → IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer(2016)529 cited
- → Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms(2019)399 cited
- → Pancreatic Cancer-Associated Stellate Cells Promote Differentiation of Myeloid-Derived Suppressor Cells in a STAT3-Dependent Manner(2013)396 cited
- → β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study(2011)202 cited
- → Enhanced bioavailability of lycopene when consumed as cis‐isomers from tangerine compared to red tomato juice, a randomized, cross‐over clinical trial(2015)196 cited
- → Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice(2011)187 cited
- → Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment(2017)169 cited
- → The Potential of CAR T Cell Therapy in Pancreatic Cancer(2018)154 cited
- → Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma(2016)153 cited
- → A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells(2010)150 cited